drugset / Trial / NCT00002102

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.

NCT00002102

Completed U.S. Bioscience
Open-labelTreatment

Summary

To provide trimetrexate glucuronate to immunosuppressed patients with Pneumocystis carinii pneumonia (PCP) for whom this investigational compound could provide significant medical benefit.

Timeline

Start
Primary completion
Completion

Publications

  • Background Feinberg J, McDermott C, Nutter J. Trimetrexate (TMTX) salvage therapy for PCP in AIDS patients with limited therapeutic options. Int Conf AIDS. 1992 Jul 19-24;8(2):B136 (abstract no PoB 3297)

Drugs

EvaluationDrugModalityDoseRoute
Subject Trimetrexate Unknown Intravenous
Background Leucovorin Small molecule Intravenous